Axumin (Blue Earth Diagnostics)
Welcome to the PulseAid listing for the Axumin drug offered from Blue Earth Diagnostics. This Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Blue Earth Diagnostics |
NON-PROPRIETARY NAME: | Fluciclovine F-18 |
SUBSTANCE NAME: | FLUCICLOVINE F-18 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-05-27 |
END MARKETING DATE: | 0000-00-00 |
Axumin HUMAN PRESCRIPTION DRUG Details:
Item Description | Axumin from Blue Earth Diagnostics |
LABELER NAME: | Blue Earth Diagnostics |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 221(mCi/mL) |
START MARKETING DATE: | 2016-05-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69932-001_982e43f0-16d2-43fd-97d4-6c9a3db8b819 |
PRODUCT NDC: | 69932-001 |
APPLICATION NUMBER: | NDA208054 |
Other FLUCICLOVINE F-18 Pharmaceutical Manufacturers / Labelers: